Addex Therapeutics's total assets for Q2 2025 were CHF8.51M, a decrease of -10.32% from the previous quarter. ADXN total liabilities were CHF1.29M for the fiscal quarter, a 8.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.